Literature DB >> 9855566

A review of plants used in the treatment of liver disease: part 1.

S Luper1.   

Abstract

Botanicals have been used traditionally by herbalists and indigenous healers worldwide for the prevention and treatment of liver disease. Clinical research in this century has confirmed the efficacy of several plants in the treatment of liver disease. Basic scientific research has uncovered the mechanisms by which some plants afford their therapeutic effects. Silybum marianum (milk thistle) has been shown to have clinical applications in the treatment of toxic hepatitis, fatty liver, cirrhosis, ischemic injury, radiation toxicity, and viral hepatitis via its antioxidative, anti-lipid peroxidative, antifibrotic, anti-inflammatory, immunomodulating, and liver regenerating effects. Picrorhiza kurroa, though less well researched than Silybum, appears to have similar applications and mechanisms of action. When compared with Silybum, the hepatoprotective effect of Picrorhiza was found to be similar, or in many cases, superior to the effect of Silybum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855566

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  56 in total

1.  Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs.

Authors:  Seung-Ki Chon; Nam-Soo Kim
Journal:  Parasitol Res       Date:  2005-09-09       Impact factor: 2.289

3.  Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Gagan Deep; Suchitra Katiyar; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

4.  The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio).

Authors:  Rui Jia; Liping Cao; Jinliang Du; Pao Xu; Galina Jeney; Guojun Yin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-22       Impact factor: 2.416

5.  High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin.

Authors:  J M Pérez-Victoria; F J Pérez-Victoria; G Conseil; M Maitrejean; G Comte; D Barron; A Di Pietro; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

6.  Hepatoprotective activity of viscosine is mediated by attenuation of hepatic macrophages and iNOS expression in CCl4-intoxicated rats.

Authors:  Hamid Ali; Nurul Kabir; Muhammad Raza Shah; Akhtar Muhammad; Safdar Ali; Shahab Mehmood; Amjad Ali; Abid Ali; Azra Jahan
Journal:  Toxicol Res (Camb)       Date:  2016-09-13       Impact factor: 3.524

Review 7.  Herbal medicines for liver diseases.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  Silymarin reduces profibrogenic cytokines and reverses hepatic fibrosis in chronic murine schistosomiasis.

Authors:  Hílton Antônio Mata-Santos; Fabianno Ferreira Dutra; Carolina Carneiro Rocha; Fabiana Gonçalves Lino; Fabiola Ramos Xavier; Leandro Andrade Chinalia; Bryan Hudson Hossy; Morgana Teixeira Lima Castelo-Branco; Anderson Junger Teodoro; Claudia N Paiva; Alexandre dos Santos Pyrrho
Journal:  Antimicrob Agents Chemother       Date:  2014-01-21       Impact factor: 5.191

Review 9.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

10.  Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo.

Authors:  Chang Chu; Shan-shan Tong; Ying Xu; Li Wang; Min Fu; Yan-ru Ge; Jiang-nan Yu; Xi-ming Xu
Journal:  Acta Pharmacol Sin       Date:  2011-06-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.